Your browser doesn't support javascript.
loading
Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma.
Ferdinandus, Justin; Zaremba, Anne; Zimmer, Lisa; Umutlu, Lale; Seifert, Robert; Barbato, Francesco; Ugurel, Selma; Chorti, Eleftheria; Grünwald, Viktor; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang Peter; Livingstone, Elisabeth.
Afiliação
  • Ferdinandus J; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstr, 55, 45147, Essen, Germany. justin.ferdinandus@uk-essen.de.
  • Zaremba A; Department of Dermatology, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen, Hufelandstr, 55, 45147, Essen, Germany. anne.zaremba@uk-essen.de.
  • Zimmer L; Department of Dermatology, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen, Hufelandstr, 55, 45147, Essen, Germany.
  • Umutlu L; Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Seifert R; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstr, 55, 45147, Essen, Germany.
  • Barbato F; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstr, 55, 45147, Essen, Germany.
  • Ugurel S; Department of Dermatology, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen, Hufelandstr, 55, 45147, Essen, Germany.
  • Chorti E; Department of Dermatology, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen, Hufelandstr, 55, 45147, Essen, Germany.
  • Grünwald V; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstr, 55, 45147, Essen, Germany.
  • Schadendorf D; Department of Dermatology, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen, Hufelandstr, 55, 45147, Essen, Germany.
  • Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstr, 55, 45147, Essen, Germany.
  • Livingstone E; Department of Dermatology, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen, Hufelandstr, 55, 45147, Essen, Germany.
Cancer Imaging ; 22(1): 11, 2022 Feb 05.
Article em En | MEDLINE | ID: mdl-35123578
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article